Antineoplaston AS2-1

AS2-1 · Burzynski Research Institute

Drug timelines are a Plus or Pro feature.

3 regulatory and trial events tracked for Antineoplaston AS2-1, covering 2016-12-16 to 2025-09-16. Get the full timeline:

Most recent: Clinical Trial Update: Study of Antineoplaston Therapy + Radiation vs. Radiation Only in Diffuse, Intrinsic, Brainstem Glioma [Phase 3]